Inactive Instrument

All News ROCE BAY Other OTC

Equities

End-of-day quote Other OTC Other stock markets
- ^USD	-

2009	ROCHE BAY PLC : Roche drug Avastin fails cancer study, shares fall	RE
2009	ROCHE BAY PLC : Roche beats recession in first quarter	RE

ROCHE BAY PLC : Roche drug Avastin fails cancer study, shares fall	22/04/09	RE
ROCHE BAY PLC : Roche beats recession in first quarter	16/04/09	RE
ROCHE BAY PLC : Roche confident for full year after Q1 sales rise	16/04/09	RE
ROCHE BAY PLC : Roche Q1 sales rise 8 percent	16/04/09	RE
ROCHE BAY PLC : Roche Q1 sales rise 8 percent, confident on FY goals	16/04/09	RE
ROCHE BAY PLC : Roche secures 96 percent of Genentech, plans to delist	26/03/09	RE
ROCHE BAY PLC : Roche controls 96.2 percent of Genentech as bid closes	26/03/09	RE
ROCHE BAY PLC : Roche's $46.8 billion Genentech deal outshines others	12/03/09	RE
ROCHE BAY PLC : Roche wins Genentech with raised $46.8 billion offer	12/03/09	RE
ROCHE BAY PLC : Roche agrees to buy Genentech for $46.8 billion	12/03/09	RE
ROCHE BAY PLC : Roche says latest Genentech bid is still fair	10/03/09	RE
ROCHE BAY PLC : Roche, Genentech in talks on $47 billion deal	09/03/09	RE
ROCHE BAY PLC : Roche, Genentech in talks for $95/shr deal	09/03/09	RE
ROCHE BAY PLC : Roche, Genentech in talks for $95 a share deal	09/03/09	RE
ROCHE BAY PLC : Roche seen sealing Genentech deal after upping bid	09/03/09	RE
ROCHE BAY PLC : Roche increases Genentech offer to $45.7 billion	06/03/09	RE
ROCHE BAY PLC : Roche ups Genentech bid to $45.7 billion	06/03/09	RE
ROCHE BAY PLC : Roche seen upping $42 billion Genentech bid after rebuff	24/02/09	RE
ROCHE BAY PLC : Roche sees slower growth but confident on Genentech	04/02/09	RE
ROCHE BAY PLC : Roche sees slower growth as profit drops 5 percent	04/02/09	RE

No results for this search